Mechanisms of atherogenic effects of bisphenol A
Mechanisms of atherogenic effects of bisphenol A
批准号:
8828205
负责人:
Changcheng Zhou
金额:
$18.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2017-09-30
关键词:
AddressAdverse effectsAffectAgonistAnimal ModelAnimalsApoE knockout mouseApolipoprotein EArterial Fatty StreakAtherosclerosisBiologicalBiological MonitoringBone Marrow TransplantationCD36 geneCardiovascular DiseasesChemicalsChronicDevelopmentDietary SteroidDoseEnvironmentEtiologyExhibitsExposure toFoam CellsFutureGenesGoalsHealthHormonesHumanIndividualLigandsLinkLipidsMediatingMolecularMusNuclear ReceptorsPathway interactionsPharmacologic SubstancePharmacologyPilot ProjectsPlayPopulationProductionReceptor ActivationRiskRisk AssessmentRoleSpecificityTestingTransgenesTransgenic MiceUncertaintyVariantXenobiotic MetabolismXenobioticsatherogenesisbasebisphenol Ablood lipidcardiovascular disorder riskconsumer productenvironmental chemicalexposed human populationgene environment interactionhuman population studyin vivoleukocyte activationmacrophagenovelpolycarbonate plasticpopulation basedpregnane X receptorreceptorscavenger receptorsensorspecies difference
中文摘要
描述(由申请人提供):这是一份R21申请,旨在研究双酚A (BPA)致动脉粥样硬化作用的机制。双酚a是一种基础化学物质,广泛用于许多消费品中的聚碳酸酯塑料中,人类接触双酚a是无处不在的。最近,多项基于人群的研究表明,较高的BPA暴露与心血管疾病(CVD)风险增加有关。然而,导致这些关联的机制尚不清楚。许多环境化学物质可以激活异体受体孕烷X受体(PXR),而PXR又作为异体传感器调节异体代谢,并在不同物种间表现出相当大的药理学差异。最近,我们在动物模型中揭示了PXR的促动脉粥样硬化作用,发现小鼠PXR的慢性激活增加了动脉粥样硬化易感性载脂蛋白E缺陷(ApoE-/-)小鼠的动脉粥样硬化。我们还证明BPA是人类而不是小鼠PXR的有效激活剂,因此,动物模型的选择对于预测BPA的人类风险评估至关重要。因此,我们培育了新型PXR人源化ApoE-/-小鼠(huPXR)。ApoE-/-,即ApoE敲除小鼠,用人类PXR转基因代替小鼠PXR),可以对人类PXR配体产生反应。我们的中心假设是,暴露于BPA的PXR的慢性激活促进了泡沫细胞的形成,增加了PXR人源化小鼠动脉粥样硬化病变的形成,从而增加了暴露个体患心血管疾病的风险。为了验证这一假设,提出了两个特定的目标:1)长期暴露于与人类暴露剂量相关的BPA是否会增加pxr人源化ApoE-/-小鼠的动脉粥样硬化?2) BPA影响动脉粥样硬化的分子途径是什么?本研究首次在合适的动物模型上研究BPA暴露对动脉粥样硬化的影响,并在分子水平上探索BPA诱导心血管疾病的精确分子机制。
英文摘要
DESCRIPTION (provided by applicant): This is an R21 application intended to investigate the mechanisms of atherogenic effects of bisphenol A (BPA). BPA is a base chemical used extensively in polycarbonate plastics in many consumer products, and human exposure to BPA is ubiquitous. Higher BPA exposure has recently been associated with an increased risk of cardiovascular disease (CVD) in multiple human population-based studies. However, the mechanisms responsible for these associations remain unknown. Many environmental chemicals can activate the xenobiotic receptor pregnane X receptor (PXR) which, in turn, acts as a xenobiotic sensor to regulate xenobiotic metabolism and exhibits considerable differences in its pharmacology across species. Very recently, we revealed PXR's pro-atherogenic effects in animal models and found that chronic activation of mouse PXR increases atherosclerosis in atherosclerosis-prone apolipoprotein E deficient (ApoE-/-) mice. We also demonstrated that BPA is a potent activator of human but not mouse PXR, consequently, the choice of animal model is paramount in predicting the human risk assessment of BPA. Therefore, we generated novel PXR- humanized ApoE-/- mice (huPXR.ApoE-/-, i.e., ApoE knockout mice with the human PXR transgene in place of mouse PXR) that can respond to human PXR ligands. Our central hypothesis is that chronic activation of PXR by exposure to BPA promotes foam cell formation and increases atherosclerotic lesion formation in PXR- humanized mice, thereby increasing the risk of CVD in exposed individuals. Two specific aims are proposed to test this hypothesis: 1) Does chronic exposure to BPA at doses relevant to human exposure increase atherosclerosis in PXR-humanized ApoE-/- mice? 2) What molecular pathway does BPA act through to influence atherogenesis? The proposed studies are the first to investigate the effects of BPA exposure on atherosclerosis in a suitable animal model, and to explore the precise molecular mechanisms by which BPA induces CVD at the molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PXR in EDC-induced cardiovascular disease
-
批准号:10640665
-
项目类别:
-
资助金额:$84.93万
-
财政年份:2023
-
负责人:Changcheng Zhou
-
依托单位:
Core D - Energy Balance and Body Composition Core
-
批准号:10225373
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2018
-
负责人:Changcheng Zhou
-
依托单位:
Core D - Energy Balance and Body Composition Core
-
批准号:10458566
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2018
-
负责人:Changcheng Zhou
-
依托单位:
Core D - Energy Balance and Body Composition Core
-
批准号:9982358
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2018
-
负责人:Changcheng Zhou
-
依托单位:
Role of IKKβ in obesity and atherosclerosis
-
批准号:10008480
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2016
-
负责人:Changcheng Zhou
-
依托单位:
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
-
批准号:9109680
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2015
-
负责人:Changcheng Zhou
-
依托单位:
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
-
批准号:9273599
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2015
-
负责人:Changcheng Zhou
-
依托单位:
Mechanisms of atherogenic effects of bisphenol A
-
批准号:8638093
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
-
批准号:9308696
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
-
批准号:8743207
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
-
批准号:8613600
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
-
批准号:10414968
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
-
批准号:10238145
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
-
批准号:8881180
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2013
-
负责人:Changcheng Zhou
-
依托单位:
IKKBETA LINKS MACROPHAGE INFLAMMATION TO OBESITY-INDUCED ATHEROSCLEROSIS
-
批准号:8360251
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2011
-
负责人:Changcheng Zhou
-
依托单位:
The role of IKKB in linking obesity to adipose tissue inflammation and adipogene
-
批准号:8602571
-
项目类别:
-
资助金额:$26.25万
-
财政年份:--
-
负责人:Changcheng Zhou
-
依托单位:
The role of IKKB in linking obesity to adipose tissue inflammation and adipogene
-
批准号:8733723
-
项目类别:
-
资助金额:$26.26万
-
财政年份:--
-
负责人:Changcheng Zhou
-
依托单位:
Core D - Energy Balance and Body Composition Core
-
批准号:9751916
-
项目类别:
-
资助金额:$19.13万
-
财政年份:--
-
负责人:Changcheng Zhou
-
依托单位:
海外基金